Dr. John A Livingston, MD MS
Claim this profileM D Anderson Cancer Center
Studies Osteosarcoma
Studies Cancer
5 reported clinical trials
10 drugs studied
Area of expertise
1Osteosarcoma
Stage IV
Stage III
2Cancer
Stage IV
Stage III
SMARCB1 positive
Affiliated Hospitals
M D Anderson Cancer Center
Clinical Trials John A Livingston, MD MS is currently running
NK Cell Therapy + Chemotherapy
for Sarcoma
The goal of this clinical research study is to find a recommended dose of donated NK cells that can be given along with chemotherapy to patients with advanced cancers. The safety and effects of this therapy will also be studied.
Recruiting1 award Phase 128 criteria
Atezolizumab + Cabozantinib
for Osteosarcoma
This trial tests atezolizumab and cabozantinib in young patients with hard-to-treat osteosarcoma. Atezolizumab helps the immune system attack cancer, while cabozantinib blocks cancer cell growth. Cabozantinib is approved for various cancers, including kidney, liver, and thyroid cancers.
Recruiting1 award Phase 2
More about John A Livingston, MD MS
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments John A Livingston, MD MS has experience with
- Cyclophosphamide
- Atezolizumab
- Cabozantinib
- Fludarabine Phosphate
- NY-ESO-1 TCR/IL-15 NK
- AttIL2-T Cells
Breakdown of trials John A Livingston, MD MS has run
Osteosarcoma
Cancer
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John A Livingston, MD MS specialize in?
John A Livingston, MD MS focuses on Osteosarcoma and Cancer. In particular, much of their work with Osteosarcoma has involved Stage IV patients, or patients who are Stage III.
Is John A Livingston, MD MS currently recruiting for clinical trials?
Yes, John A Livingston, MD MS is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that John A Livingston, MD MS has studied deeply?
Yes, John A Livingston, MD MS has studied treatments such as Cyclophosphamide, Atezolizumab, Cabozantinib.
What is the best way to schedule an appointment with John A Livingston, MD MS?
Apply for one of the trials that John A Livingston, MD MS is conducting.
What is the office address of John A Livingston, MD MS?
The office of John A Livingston, MD MS is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.